Breast Cancer
The Swiss drugmaker said Afinitor had been used in combination with exemestane, which is produced by Pfizer, and that its study of post-menopausal women with advanced breast cancer had been halted
early after positive interim results.
"Based on these study results, this combination has the potential to extend the time until chemotherapy is needed for these patients," Herve Hoppenot, president of the Novartis oncology unit, said in
a statement..
Source: http://www.irishtimes.com/newspaper/breaking/2011/0705/breaking9.htm
Created by: paris | Created at: 03:05 PM





Loading...